Interferonopathien sind Erkrankungen des der Interferon-vermittelten Signalkaskade. Solche Erkrankungen manifestieren sich vor allem in einer gestörten Infektabwehr aber auch in Autoinflammatorischen Erkrankungen und verschiedenen Dysmorphien.
1. |
Dale RC et al. (2000) Familial systemic lupus erythematosus and congenital infection-like syndrome. |
2. |
Singleton EB et al. (1973) An unusual syndrome of widened medullary cavities of the metacarpals and phalanges, aortic calcification and abnormal dentition. |
3. |
Gay BB et al. (1976) A syndrome of widened medullary cavities of bone, aortic calcification, abnormal dentition, and muscular weakness (the Singleton-Merten syndrome). |
4. |
None (1888) Harveian Lectures on Lupus. |
5. |
None (2005) The Gordon Wilson Lecture: The clinical legacy of Jonathan Hutchinson (1828-1913): syndromology and dysmorphology meet genomics. |
6. |
None (1952) The clinical observations of Jonathan Hutchinson. |
7. |
Weston WL et al. () Childhood pernio and cryoproteins. |
8. |
Crow YJ et al. (2009) Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. |
9. |
None (2008) Aicardi-Goutières syndrome (AGS). |
10. |
Lanzi G et al. (2005) The natural history of Aicardi-Goutières syndrome: follow-up of 11 Italian patients. |
11. |
Crow YJ et al. (2004) Congenital glaucoma and brain stem atrophy as features of Aicardi-Goutières syndrome. |
12. |
Crow YJ et al. (2003) Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism. |
13. |
Feigenbaum A et al. (2013) Singleton-Merten syndrome: an autosomal dominant disorder with variable expression. |
14. |
Aicardi J et al. (2000) Systemic lupus erythematosus or Aicardi-Goutières syndrome? |
15. |
Crow YJ et al. (2000) Aicardi-Goutières syndrome displays genetic heterogeneity with one locus (AGS1) on chromosome 3p21. |
16. |
Goutières F et al. (1998) Aicardi-Goutières syndrome: an update and results of interferon-alpha studies. |
17. |
Akwa Y et al. (1998) Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. |
18. |
McEntagart M et al. (1998) Aicardi-Goutières syndrome: an expanding phenotype. |
20. |
Raymond AA et al. (1996) Brain calcification in patients with cerebral lupus. |
21. |
Tolmie JL et al. (1995) The Aicardi-Goutières syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis). |
22. |
Aicardi J et al. (1984) A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. |
23. |
Babbitt DP et al. (1969) Idiopathic familial cerebrovascular ferrocalcinosis (Fahr's disease) and review of differential diagnosis of intracranial calcification in children. |
24. |
Giroud M et al. (1986) A case of progressive familial encephalopathy in infancy with calcification of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. |
25. |
Schorr S et al. (1976) Spondyloenchondrodysplasia. Enchondromatomosis with severe platyspondyly in two brothers. |
26. |
Pansuriya TC et al. (2010) Enchondromatosis: insights on the different subtypes. |
28. |
Kulkarni ML et al. (2007) A syndrome of immunodeficiency, autoimmunity, and spondylometaphyseal dysplasia. |
29. |
Bhargava R et al. (2005) Autosomal dominant inheritance of spondyloenchondrodysplasia. |
30. |
Tüysüz B et al. (2004) Spondyloenchondrodysplasia: clinical variability in three cases. |
31. |
Uhlmann D et al. (1998) Spondyloenchondrodysplasia: several phenotypes--the same syndrome. |
32. |
Sauvegrain J et al. () [Multiple chondroma affecting the spine: spondylo-enchondroplasia and other forms (author's transl)]. |
33. |
Chagnon S et al. (1985) [Spondylo-enchondrodysplasia]. |
34. |
Menger H et al. (1989) Spondyloenchondrodysplasia. |
35. |
Halal F et al. (1991) Generalized enchondromatosis in a boy with only platyspondyly in the father. |
36. |
Robinson D et al. (1991) Spondyloenchondrodysplasia. A rare cause of short-trunk syndrome. |
37. |
Mehta L et al. (1986) Familial calcification of the basal ganglia with cerebrospinal fluid pleocytosis. |
38. |
Spranger J et al. (1978) Two peculiar types of enchondromatosis. |
39. |
Gustavson KH et al. (1978) Spondylometaphyseal dysplasia in two sibs of normal parents. |
40. |
Mateen FJ et al. (2010) Evolution of a tumor-like lesion in cerebroretinal vasculopathy and TREX1 mutation. |
41. |
Cohn AC et al. (2005) Novel ophthalmological features in hereditary endotheliopathy with retinopathy, nephropathy and stroke syndrome. |
42. |
Siveke JT et al. (2003) Evidence for systemic manifestations in cerebroretinal vasculopathy. |
44. |
Weil S et al. (1999) Cerebroretinal vasculopathy mimicking a brain tumor: a case of a rare hereditary syndrome. |
45. |
Terwindt GM et al. (1998) Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. |
46. |
Gutmann DH et al. (1989) Hereditary retinal vasculopathy with cerebral white matter lesions. |
47. |
Egritas O et al. (2009) Tricho-hepato-enteric syndrome presenting with mild colitis. |
48. |
Girschick H et al. (2015) Severe immune dysregulation with neurological impairment and minor bone changes in a child with spondyloenchondrodysplasia due to two novel mutations in the ACP5 gene. |
49. |
Jen J et al. (1997) Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). |
50. |
Grand MG et al. (1988) Cerebroretinal vasculopathy. A new hereditary syndrome. |
51. |
Storimans CW et al. () A new autosomal dominant vascular retinopathy syndrome. |
52. |
Rice GI et al. (2013) Synonymous mutations in RNASEH2A create cryptic splice sites impairing RNase H2 enzyme function in Aicardi-Goutières syndrome. |
53. |
Rice G et al. (2007) Clinical and molecular phenotype of Aicardi-Goutieres syndrome. |
54. |
Crow YJ et al. (2006) Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. |
55. |
Sanchis A et al. (2005) Genetic syndromes mimic congenital infections. |
56. |
Fabre A et al. (2012) SKIV2L mutations cause syndromic diarrhea, or trichohepatoenteric syndrome. |
57. |
Briggs TA et al. (2016) Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive Survey. |
58. |
Bilginer Y et al. (2016) Three cases of spondyloenchondrodysplasia (SPENCD) with systemic lupus erythematosus: a case series and review of the literature. |
59. |
de Bruin C et al. (2016) Severe Short Stature in Two Siblings as the Presenting Sign of ACP5 Deficiency. |
60. |
Crow YJ et al. (2006) Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. |
61. |
Briggs TA et al. (2011) Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. |
62. |
Lausch E et al. (2011) Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. |
63. |
Navarro V et al. (2008) Two further cases of spondyloenchondrodysplasia (SPENCD) with immune dysregulation. |
64. |
Renella R et al. (2006) Spondyloenchondrodysplasia with spasticity, cerebral calcifications, and immune dysregulation: clinical and radiographic delineation of a pleiotropic disorder. |
65. |
None (1958) [A case of infantile generalized lupus erythematosus with unusual bone changes]. |
66. |
Roifman CM et al. (2003) A novel syndrome of combined immunodeficiency, autoimmunity and spondylometaphyseal dysplasia. |
67. |
Frydman M et al. (1990) Possible heterogeneity in spondyloenchondrodysplasia: quadriparesis, basal ganglia calcifications, and chondrocyte inclusions. |
68. |
Zhang X et al. (2015) Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation. |
69. |
Bogunovic D et al. (2012) Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. |
70. |
Crow YJ et al. (2014) Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia. |
71. |
Livingston JH et al. (2014) A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1. |
72. |
Leshinsky-Silver E et al. (2011) A large homozygous deletion in the SAMHD1 gene causes atypical Aicardi-Goutiéres syndrome associated with mtDNA deletions. |
73. |
Black DN et al. (1988) Encephalitis among Cree children in northern Quebec. |
74. |
Ali M et al. (2006) A second locus for Aicardi-Goutieres syndrome at chromosome 13q14-21. |
75. |
Vogt J et al. (2013) Striking intrafamilial phenotypic variability in Aicardi-Goutières syndrome associated with the recurrent Asian founder mutation in RNASEH2C. |
76. |
Jang MA et al. (2015) Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome. |
77. |
Meuwissen ME et al. (2016) Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome. |
78. |
Knoblauch H et al. (2003) Two brothers with findings resembling congenital intrauterine infection-like syndrome (pseudo-TORCH syndrome). |
79. |
Rutsch F et al. (2015) A specific IFIH1 gain-of-function mutation causes Singleton-Merten syndrome. |
80. |
Oda H et al. (2014) Aicardi-Goutières syndrome is caused by IFIH1 mutations. |
81. |
Rice GI et al. (2014) Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. |
82. |
Valverde I et al. (2010) Singleton-merten syndrome and impaired cardiac function. |
83. |
Ravenscroft JC et al. (2011) Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus. |
84. |
Rice GI et al. (2012) Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. |
85. |
Dale RC et al. (2010) Familial Aicardi-Goutières syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures. |
86. |
Rice GI et al. (2009) Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. |
87. |
Adang LA et al. (2018) Aicardi goutières syndrome is associated with pulmonary hypertension. |
88. |
Cuadrado E et al. (2015) Phenotypic variation in Aicardi-Goutières syndrome explained by cell-specific IFN-stimulated gene response and cytokine release. |
89. |
Haaxma CA et al. (2010) A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi-Goutières syndrome. |
90. |
Richards A et al. (2007) C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. |
91. |
Lee-Kirsch MA et al. (2007) Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. |
92. |
Lee-Kirsch MA et al. (2007) A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. |
93. |
Rice G et al. (2007) Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. |
94. |
Lee-Kirsch MA et al. (2006) Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. |